id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0247-0300,FDA,FDA-2009-N-0247,Report on Good Guidance Practices Improving Efficiency and Transparency; Availability,Notice,Availability of Document,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,2012-02-29T04:59:59Z,2011-12-30T14:36:05Z,2011-33573,0,0,0900006480f8b7c2
FDA-2009-N-0247-0282,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data - Report,Other,Report,2011-10-04T04:00:00Z,2011,10,2011-10-04T04:00:00Z,2011-12-03T04:59:59Z,2012-09-24T13:51:34Z,,0,0,0900006480f4b7a6
FDA-2009-N-0247-0281,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data; Availability,Notice,Notice of Availability,2011-10-04T04:00:00Z,2011,10,2011-10-04T04:00:00Z,2011-12-03T04:59:59Z,2011-10-04T14:23:45Z,2011-25354,0,0,0900006480f4b687
FDA-2009-N-0247-0278,FDA,FDA-2009-N-0247,BioMarin Pharmaceutical Inc. - Request for Appearance,Other,Appearance Request,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2013-07-27T22:56:23Z,,0,0,0900006480a3be58
FDA-2009-N-0247-0277,FDA,FDA-2009-N-0247,Nielsen Hobbs - Request for Appearance,Other,Appearance Request,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2013-08-11T03:04:32Z,,0,0,0900006480a3bdd5
FDA-2009-N-0247-0276,FDA,FDA-2009-N-0247,BioMarin Pharmaceutical Inc. - Request for Appearance,Other,Appearance Request,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2013-08-11T04:35:53Z,,0,0,0900006480a3bdae
FDA-2009-N-0247-0260,FDA,FDA-2009-N-0247,FDA Transparency Initiative: Improving Transparency to Regulated Industry,Notice,N-Notice,2011-01-07T05:00:00Z,2011,1,2011-01-07T05:00:00Z,2011-03-09T04:59:59Z,2011-03-03T20:47:30Z,2011-71,0,0,0900006480bc6d30
FDA-2009-N-0247-0261,FDA,FDA-2009-N-0247,"Phase III Report_Final, January 2011 - [FDA Transparency Initiative: Improving Transparency to Regulated Industry] - Report",Other,RPT-Report,2011-01-07T05:00:00Z,2011,1,2011-01-07T05:00:00Z,,2011-01-07T15:34:54Z,,0,0,0900006480bc65f2